These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1481607)

  • 21. [Use of hybrid strains of S, typhi and S. typhimurium for characterizing the biological activity of individual Salmonella antigens by the alternative recording of the experimental results].
    Levina LA; Zaĭdner IG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Aug; (8):31-6. PubMed ID: 335742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of macrophages in the development of an immune response to typhoid bacterial polysaccharide Vi-antigen].
    Vysokodvorova RI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):67-70. PubMed ID: 4471632
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccines against typhoid fever.
    Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
    Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular heterogeneity of preparations of endotoxins of bacteria of the typhoid-paratyphoid group. II. Antigenic structure and biological activity of high and low molecular fractions].
    Shapiro NI; Vasil'eva TG; Moskvicheva IV; Dudkina MI; Kruglikhina ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Nov; 48(11):35-9. PubMed ID: 5135464
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
    Tacket CO; Losonsky G; Taylor DN; Baron LS; Kopecko D; Cryz S; Levine MM
    J Infect Dis; 1991 Apr; 163(4):901-4. PubMed ID: 2010645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological properties of antigens and chemical characteristics of specific polysaccharides obtained from S. typhi bacteria exposed to gamma irradiation.
    Shibayeva IV; Izvekova AV; Ivanov KK; Tumanyan MA
    J Hyg Epidemiol Microbiol Immunol; 1973 Mar; 17(3):357-63. PubMed ID: 4795567
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunization with the conjugate vaccine Vi-CRM₁₉₇ against Salmonella typhi induces Vi-specific mucosal and systemic immune responses in mice.
    Fiorino F; Ciabattini A; Rondini S; Pozzi G; Martin LB; Medaglini D
    Vaccine; 2012 Sep; 30(43):6111-4. PubMed ID: 22705173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunologic efficacy of typhoid alcoholic vaccine enriched with Vi-antigen in opisthorchiasis].
    Baranova NA; Peklo GN; Razmashkina AP
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Nov; 49(11):66-9. PubMed ID: 4645855
    [No Abstract]   [Full Text] [Related]  

  • 30. Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.
    Szu SC; Stone AL; Robbins JD; Schneerson R; Robbins JB
    J Exp Med; 1987 Nov; 166(5):1510-24. PubMed ID: 3681191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vi capsular polysaccharide: Synthesis, virulence, and application.
    Hu X; Chen Z; Xiong K; Wang J; Rao X; Cong Y
    Crit Rev Microbiol; 2017 Aug; 43(4):440-452. PubMed ID: 27869515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of Vi capsular polysaccharide vaccine evaluated for three years in Korea.
    Kim YR; Yoo JH; Hur JK; Kang JH; Shin WS; Kang MW
    J Korean Med Sci; 1995 Oct; 10(5):314-7. PubMed ID: 8750055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials.
    Arya SC; Agarwal N
    Vaccine; 2008 Jan; 26(3):291. PubMed ID: 18082292
    [No Abstract]   [Full Text] [Related]  

  • 34. [The problem of designing typhoid vaccines].
    Tymchuk SN; Boĭchenko MN; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (4):86-90. PubMed ID: 9027185
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune response to Vi polysaccharide, heat-killed whole cells, and outer membrane protein of Salmonella typhi.
    Hosny Ael-D; Diab MR; Khattab RA; Awad HO
    J Infect Dev Ctries; 2015 Jul; 9(6):642-9. PubMed ID: 26142675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characteristics of Peyer's patch lymphoid cells. II. Lipopolysaccharide is thymus dependent.
    Kagnoff MF; Billings P; Cohn M
    J Exp Med; 1974 Feb; 139(2):407-13. PubMed ID: 4589992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single shot at Salmonella typhi: a new typhoid vaccine with pediatric advantages.
    Hall CB
    Pediatrics; 1995 Aug; 96(2 Pt 1):348-50. PubMed ID: 7630698
    [No Abstract]   [Full Text] [Related]  

  • 38. A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses.
    Das S; Chowdhury R; Ghosh S; Das S
    Vaccine; 2017 Aug; 35(35 Pt B):4523-4531. PubMed ID: 28739115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The characteristics of an antigenic preparation from Salmonella typhi Ty(2)4446 isolated using hydroxylamine hydrochloride].
    Sergeev VV; Tsvetkova NV; Iastrebova NE; Kaverina KG; Ian'kova MM; Sokolova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):65. PubMed ID: 8079573
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa.
    Arya SC
    Vaccine; 1997 Feb; 15(2):244. PubMed ID: 9066045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.